Carcinoembryonic
Antigen (CEA) Market
size is driven by increasing incidence rate for cancer disease especially
colorectal cancer is one of the important factor contributing to the growth. Global
Carcinoembryonic Antigen Market is set to register profitable growth in the
near future and surpass USD 2.8 billion by 2023. This growth is attributed to
factors including consistent technology advancements, development of novel
biomarkers and growing prevalence of cancer. Global Market Insights, Inc.
announces the addition of a new research report on Carcinoembryonic Antigen
(CEA) market to their offering.
Order This Report by calling Global
Market Insights, Inc. at 1-888-689-0688 (Toll Free) or 1-302-846-7766.
The
differentiating factor of carcinoembryonic antigen market report by Global
Market Insights, Inc. when compared with other, similar syndicated research
studies includes a 360-degree synopsis of trends for a period of more than 10
years including historic information as well as future outlook. Business
focussed multiple trends for carcinoembryonic antigen industry are discussed
along with regional trends to offer an overall view of the market. The
‘industry insights’ chapter of this research provides the most comprehensive
analysis of carcinoembryonic antigen market covering segmentation, size,
forecasts, ecosystem analysis and more. Industry impact forces (regional and
global) that cover growth drivers and challenges, growth potential analysis, a
strategy dashboard for competitive landscape of carcinoembryonic antigen market support this sector specific
data and information points.
The report
gives you a basic overview of the CEA market with market definition,
applications, segmentation, and value chain analysis. The report covers
competitive landscape with the leading company profiles and recent events in
the industry. Equipped with all vital information including current scenario,
forecasts, and future predictions, it offers insights to foresee challenges and
opportunities that will aid in making informed decisions.
Growing
demand for minimally invasive diagnostics procedures is projected to contribute
a significant part in shaping market growth. Increasing geriatric population is
another key factor to intensify the Carcinoembryonic Antigen market growth. The
development of novel combination biomarkers and initiatives by the government
concerning improved diagnostic rates are likely to open growth avenues for CEA
market. The advent of various tumor markers, which can be used along with CEA
to monitor or diagnose colorectal cancer is predicted to influence the market
growth positively.
To
access sample pages or view this report titled, “Carcinoembryonic Antigen (CEA)
Market Size By Application (Colorectal, Pancreatic, Ovarian, Breast, Thyroid
Cancer], Industry Analysis Report, Regional Outlook (U.S., Canada, Germany,
France, Spain, Japan, China, India, Mexico, Brazil, South Africa), Application
Potential, Competitive Market Share & Forecast, 2016 – 2023”
in detail along with the table of contents, please click on the link below:
North
America, hinged on the U.S. Carcinoembryonic Antigen market size, is predicted
to lead the segment with estimations of USD 800 million in 2016. Growing
awareness about detecting cancer at an early stage and improved health care
services for cancer therapeutics are anticipated to propel growth. Asia-Pacific
region driven by India and China is targeted to foresee growing prevalence of
cancer owing to changes in lifestyle and aging population in the area. The
growth is mainly attributed to improved treatment facilities and high
disposable income. The Asia-Pacific market share can surpass USD 380 million in
the near future.
Colorectal
cancer tops the application segment and is expected to foresee growth over the
forecast period. Breast cancer segment is likely to be the most lucrative with
estimations of over USD 460 million at over 7% CAGR during the projected time
frame.
The key players in global carcinoembryonic antigen
market include:
·
Quest Diagnostics
·
Roche Diagnostics
·
GenWay Biotech, Inc.
·
Abbott Diagnostics
Focus
on early detection methods and product innovation owing to rising demand for
minimally invasive procedures is a key strategy adopted by the key participants
in the market.
Bioreactor Market Size By
Cell (Mammalian Cells, Bacterial Cells, Yeast Cells, Others), By Molecule
(Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene
Therapy, Others), By Technology (Wave-Induced Motion SUB, Stirred SUB, Single
Use Bubble Column, Other SUB), By End-Use ( R&D organizations, Biopharma
Manufacturers, CMOs) Industry Analysis Report, Regional Outlook (U.S., Canada,
Germany, UK, Spain, Italy, France, Netherland, Denmark, China, Japan, India,
South Korea, Australia, Singapore, Brazil, Mexico, UAE, South Africa),
Application Development, Price Trend, Competitive Landscape & Forecast,
2017 – 2024
About Global Market Insights:
Global Market
Insights, Inc., headquartered in Delaware, U.S., is a global market research
and consulting service provider; offering syndicated and custom research
reports along with growth consulting services. Our business intelligence and
industry research reports offer clients with penetrative insights and
actionable market data specially designed and presented to aid strategic
decision making. These exhaustive reports are designed via a proprietary
research methodology and are available for key industries such as chemicals,
advanced materials, technology, renewable energy and biotechnology.
Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter
No comments:
Post a Comment